Randomized Clinical Trial: The Clinical Effects of Herb-Partitioned Moxibustion in Patients with Diarrhoea-Predominant Irritable Bowel Syndrome

Figure 3

Primary endpoint: changes of the GSRS total score from baseline to week 4 (end of the treatment) and week 8 (follow-up period) for the three groups in the FAS population. HM: herb-partitioned moxibustion; FM: farina-partitioned moxibustion; PB, orally taking pinaverium bromide.